Leaders | Vested interests

The push for shareholder democracy should be accelerated

It is still too hard for small shareholders to be heard

KEEPING SHAREHOLDERS satisfied used to be straightforward. If a firm could announce juicy profits, healthy cashflow and a perky dividend at the annual general meeting (AGM), applause was assured and few hard questions would be asked. But in recent years these meetings have shifted from routine talk of balance-sheets to loud battles over companies’ broader purpose. Where once it was enough for bosses to nod to some vague notion of “stakeholder capitalism”, now some investors demand that they present detailed strategies on everything from the environment to racial justice and even abortion. More, too, are highlighting the dissonance between companies’ stated values and their political donations. Shareholders at American firms face a record volume of proposals on environmental and social issues: 576 resolutions as of April 12th, up from 499 last year. In the coming weeks an unprecedented number will be put to a vote.

This article appeared in the Leaders section of the print edition under the headline “Vested interests”

The Fed that failed

From the April 23rd 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Leaders

Keir Starmer surrounded by the Eu stars

Sir Keir Starmer should aim higher in his reset with the EU

And he needs to be clearer about what Britain wants

illustration of a world map outlined by a single red electrical cord, with a plug at one end and a socket at the other

To make electricity cheaper and greener, connect the world’s grids

Less than 3% of the world’s power is internationally traded—a huge wasted opportunity


Chinese AI is catching up, posing a dilemma for Donald Trump

The success of cheap Chinese models threatens America’s technological lead


America has an imperial presidency

And in Donald Trump, an imperialist president for the first time in over a century

Tariffs will harm America, not induce a manufacturing rebirth

Donald Trump’s pursuit of tariffs will make the world poorer—and America, too 

How to improve clinical trials

Involving more participants can lead to new medical insights